Capabilities:
Economic Analysis
To develop comprehensive strategies, executives need to quantify the impact of their therapies on patient outcomes through cost-effectiveness, cost-benefit, cost-utility, and cost-minimization analyses. Properly executing this economic research and analysis requires the collection and interpretation of data residing throughout many sectors of the industry. Most organizations do not have the informational access or analytic availability to produce these critical forecasts with the breadth of scenarios that are necessary to make informed decisions.
Putnam's reality based economic analysis capabilities help you understand the business environment that you are working within to answer the following key questions:
- How do we improve the accuracy of our forecasts?
- How do we close the gap between internal estimates and likely scenarios?
- How will reference pricing influence our strategy?
- What is the impact of legislative market intervention?
- What is managed care's actual net cost of our product versus competitors?
We conduct comprehensive economic analyses at all stages of the life cycle value chain. The methods we employ to provide valuable information for revenue forecasts, return on investment trends, and the qualitative and quantitative impact of therapies include:
- Constructing independent, objective forecast models
- Analyzing patient charts and outcomes
- Conducting detailed scenario analyses with MCOs, M.D.s, hospital directors, etc.
- Deconstructing and analyzing in-depth large scale data sets through regression modeling, factor/cluster analysis, and CHAID analysis
- Commissioning and fielding primary research to gain further understanding of the market dynamics including the use of techniques such as conjoint analysis, discrete choice analysis, price sensitivity research and forced trade off methods